Cheshire & Merseyside carries a huge burden of health issues caused by cardiovascular disease (CVD). In the UK, there are around 7 million people living with CVD, and healthcare costs relating to the disease are estimated at £9 billion annually.
Stroke, a preventable disease, is the fourth single leading cause of death in the UK and the single largest cause of complex disability.
In Liverpool, CVD accounts for a fifth of all premature deaths. It remains a significant source of health inequalities and contributes directly to poorer life expectancy in the most deprived areas of where we live.
To address this, the Liverpool Centre for Cardiovascular Science (LCCS) was formed, a collaboration between founding members – Liverpool Heart & Chest Hospital, Liverpool John Moores University, Liverpool Health Partners, and the University of Liverpool.
Professor Gregory Lip is leading the initiative to develop the LCCS into an internationally renowned research centre that is relevant to local population needs and beyond. The LCCS is a virtual integrated academic NHS centre for the advancement of cardiovascular and stroke research.
The challenge the LCCS faces is to develop and implement an integrated ‘bed to bedside’ model that integrates personnel, results, resources and facilities from across our partner institutions and beyond.
Prevention, early detection and treatment of CVD can help patients live longer, healthier lives.
The potential benefits to society of discoveries and advancement in CVD science are enormous on a local, national and global level.
*CVD includes coronary heart disease, stroke, peripheral arterial disease, vascular dementia, chronic kidney disease, cardiac arrhythmia, type 2 diabetes, sudden cardiac death and heart failure.